Polus Bio Pharm Faces Embezzlement and Breach of Trust Charges Amounting to 23.5 Billion Won
[Asia Economy Reporter Oh Ju-yeon] Polus Bio Pharm announced on the 23rd that embezzlement and breach of trust charges amounting to 23.5 billion KRW have occurred. This corresponds to 26.76% of its equity capital.
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- [Breaking] KOSPI Surges Over 8%, Breaks Through 7,800 Points
- Taiwan Unveils Bold Plan: Monthly Allowance for Children Under 18 to Tackle Low Birth Rate
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!['WHO Declares International Public Health Emergency' Why the Untreatable 'Variant Ebola' Is More Deadly Than COVID-19 [Reading Science]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052110164072055_1779326201.png)
!["Please Help Us": How Much Do Those Bowing 90 Degrees These Days Actually Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
